238 related articles for article (PubMed ID: 36060969)
1. Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome.
Xing C; Zhao H; Zhang J; He B
Front Endocrinol (Lausanne); 2022; 13():945609. PubMed ID: 36060969
[TBL] [Abstract][Full Text] [Related]
2. Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial.
Zhao H; Zhang J; Xing C; Cheng X; He B
J Ovarian Res; 2024 Feb; 17(1):42. PubMed ID: 38374053
[TBL] [Abstract][Full Text] [Related]
3. Canagliflozin combined with metformin versus metformin monotherapy for endocrine and metabolic profiles in overweight and obese women with polycystic ovary syndrome: A single-center, open-labeled prospective randomized controlled trial.
Zhang J; Xing C; Cheng X; He B
Front Endocrinol (Lausanne); 2022; 13():1003238. PubMed ID: 36147577
[TBL] [Abstract][Full Text] [Related]
4. Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
Liao M; Li X; Zhang H; Zhou L; Shi L; Li W; Shen R; Peng G; Zhao H; Shao J; Wang X; Sun Z; Zheng H; Long M
Endocrine; 2024 Jan; 83(1):227-241. PubMed ID: 37653215
[TBL] [Abstract][Full Text] [Related]
5. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome.
Elkind-Hirsch K; Marrioneaux O; Bhushan M; Vernor D; Bhushan R
J Clin Endocrinol Metab; 2008 Jul; 93(7):2670-8. PubMed ID: 18460557
[TBL] [Abstract][Full Text] [Related]
6. Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study.
Elkind-Hirsch KE; Shaler D; Harris R
J Diabetes Complications; 2020 Apr; 34(4):107548. PubMed ID: 32046931
[TBL] [Abstract][Full Text] [Related]
7. Short-term effect of beinaglutide combined with metformin versus metformin alone on weight loss and metabolic profiles in obese patients with polycystic ovary syndrome: a pilot randomized trial.
Wen Q; Fang S; Liang Y; Tian Y; Chen Y; Yuan J; Chen Q
Front Endocrinol (Lausanne); 2023; 14():1156521. PubMed ID: 37347114
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
9. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Lin XF; Wu RR; Du J; Liao YC; Du Y; Ye Y; Wang Y; Zhang XB; Wu C; Chen A
Clin Exp Obstet Gynecol; 2015; 42(3):315-20. PubMed ID: 26152001
[TBL] [Abstract][Full Text] [Related]
10. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
Xing C; Li C; He B
J Clin Endocrinol Metab; 2020 Sep; 105(9):2950-63. PubMed ID: 32490533
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
Wu J; Zhu Y; Jiang Y; Cao Y
Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
[TBL] [Abstract][Full Text] [Related]
12. Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study.
Jensterle M; Salamun V; Kocjan T; Vrtacnik Bokal E; Janez A
J Ovarian Res; 2015 Jun; 8():32. PubMed ID: 26032655
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
14. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
Song J; Shen H; Li J; Huang Z; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome.
Nazirudeen R; Sridhar S; Priyanka R; Sumathi B; Natarajan V; Subbiah E; Raghavan KS; Sangumani J
Clin Endocrinol (Oxf); 2023 Aug; 99(2):198-205. PubMed ID: 37265016
[TBL] [Abstract][Full Text] [Related]
16. Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study.
Elkind-Hirsch KE; Chappell N; Shaler D; Storment J; Bellanger D
Fertil Steril; 2022 Aug; 118(2):371-381. PubMed ID: 35710599
[TBL] [Abstract][Full Text] [Related]
17. Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin.
Jensterle Sever M; Kocjan T; Pfeifer M; Kravos NA; Janez A
Eur J Endocrinol; 2014 Mar; 170(3):451-9. PubMed ID: 24362411
[TBL] [Abstract][Full Text] [Related]
18. Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study.
Tao T; Zhang Y; Zhu YC; Fu JR; Wang YY; Cai J; Ma JY; Xu Y; Gao YN; Sun Y; Fan W; Liu W
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1420-e1432. PubMed ID: 32995892
[TBL] [Abstract][Full Text] [Related]
19. Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome.
Ma RL; Deng Y; Wang YF; Zhu SY; Ding XS; Sun AJ
Chin Med J (Engl); 2021 Nov; 134(23):2882-2889. PubMed ID: 34732660
[TBL] [Abstract][Full Text] [Related]
20. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Song J; Ruan X; Gu M; Wang L; Wang H; Mueck AO
Gynecol Endocrinol; 2018 May; 34(5):413-417. PubMed ID: 29172796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
